---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004887"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:51:40.695304+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics ups ATM offering capacity to $11.2M, adds $6.1M

## Summary
- Increased maximum ATM offering from $5.1M to $11.2M under existing sales agreement.
- Filed prospectus supplement for $6.1M of common stock; $5.0M already previously sold.
- Move provides additional equity capital for company's ongoing operations.

## SEC filing metadata
- accession: 0001493152-25-004887
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315225004887/0001493152-25-004887-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315225004887/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004887
- JSON: https://secwatch.observer/filing/0001493152-25-004887.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004887.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.